ATOPIC DERMATITIS (AD)

This study looked at the safety and effectiveness of upadacitinib, a drug already approved for rheumatoid arthritis, atopic dermatitis, ankylosing spondylitis, and psoriatic arthritis. About 2,369 Korean adults took the drug as prescribed by their doctor and were followed for 28 …

This study tested an experimental drug called EVO301 in 71 adults with moderate-to-severe atopic dermatitis (eczema). The goal was to see if the drug is safe and can reduce the severity and extent of eczema compared to a placebo. Participants received either EVO301 or a dummy tre…

This study tested a new ointment called CGB-500 for people aged 12 and older with atopic dermatitis (eczema). Participants applied the ointment and a comparison drug to different skin areas twice daily for four weeks. The goal was to see if CGB-500 safely reduces eczema severity.…

This early-stage study tested a new drug called ENV-294 in 9 adults with moderate-to-severe atopic dermatitis (eczema). The main goal was to see if the drug is safe and tolerable when taken daily for 28 days. Researchers also looked for any changes in eczema severity. This is a f…

This study tested an experimental ointment called MH004 in 160 healthy adults and people with mild to moderate eczema. The goal was to see if it is safe and can reduce skin symptoms like redness and itching. Participants applied the ointment for up to 4 weeks, and researchers mea…

This study tested an experimental drug called LW402 in 144 adults with moderate-to-severe atopic dermatitis (eczema). The goal was to see if the drug reduces eczema severity, measured by a 50% improvement in skin symptoms after 12 weeks. Participants were randomly assigned to rec…

This study tested whether a new ointment called CGB-500, containing the drug tofacitinib, can safely improve atopic dermatitis (eczema) in people aged 12 and older. 180 participants used either the ointment or a placebo daily for 8 weeks. Researchers measured changes in skin area…

This study tested whether a cream containing N-acetyl cysteine (NAC) helps people with mild to moderate eczema (atopic dermatitis). 100 adults used either the NAC cream or a plain moisturizer. The goal was to see if NAC could reduce harmful bacteria on the skin and improve eczema…

This study tested a special SPF50+ sunscreen on 42 adults with mild to moderate atopic dermatitis (eczema). The goal was to see if the sunscreen is gentle on sensitive skin and helps maintain skin barrier health. Participants used the product over 22 days, including sun exposure …

This study tested an ointment called MH004 in 375 people aged 12 and older with mild to moderate eczema (atopic dermatitis). The goal was to see if it safely clears or nearly clears skin within 4 to 8 weeks. Participants used the ointment or a placebo cream, and those who finishe…

This study tested a cream called roflumilast (ZORYVE®) on 354 people aged 6 and older with mild to moderate atopic dermatitis (eczema). Participants applied the cream or a placebo once daily for 4 weeks. The goal was to see if the cream could clear or nearly clear the skin rash. …

This study tested Revodiol Calming Cream on 42 children and adults with mild-to-moderate atopic dermatitis (eczema). Participants applied the cream twice daily for 56 days under a dermatologist's care. The goal was to see if the cream improved skin hydration, reduced redness and …

This early-stage study tested a new drug called VC005 in 11 teenagers aged 12-18 with mild to moderate atopic dermatitis (eczema). The main goal was to check safety and how the drug moves through the body. It was a small, open-label study with no comparison group, so it only give…

This study tested a strong SPF50+ sunscreen on 22 children with atopic dermatitis (eczema) to see if it was gentle on their skin. Doctors checked for skin reactions and parents gave feedback on how well the product worked. The goal was to find a safe sun protection option for kid…

This study looked at the safety of using dupilumab during pregnancy in women with atopic dermatitis or asthma. Researchers compared pregnancy and infant outcomes between women who took dupilumab and those who did not. The goal was to see if the drug increased the risk of birth de…